ABC
La quinta malattia
FRANCO PANIZON
Clinica Pediatrica dell’Università di Trieste, IRCCS “Burlo Garofolo”
Gennaio 1999 - pagg. 50 -52
Parole chiave
Classificazione MeSH
Bibliografia
1. Cossart YE, Feld AM, Cant B, Widdow D:
Parvovirus-like particles in human sera. Lancet
i, 72, 1975.
2. Mann JR, Carter KP, Walker RA, et al: Anaemic crisis in sickle cell disease. J Clin Path 28, 341, 1975.
3. Serjeant GR, Mason K, Topley JM, Serjeant NE: Outbreak of aplastic crises in sickle cell anaemia associated with parvoviru-like agent. Lancet ii, 595, 1981.
4. Rao KRP, Patel AR, Anderson MJ, et al: Infections with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med 98, 930, 1983.
5. Cohen BJ, Mortimer PP, Ferreira MS: Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus. J Hyg 91, 113, 1983.
6. Couronce AM, Ferchal F, Morinet F, et al: Human parvovirus infections in France. Lancet i, 160, 1984
7. Anderson MJ, Jones SE, Fisher-Hoch SP, et al: Human parvovirus. The cause of erithema infectiosum (fifth disease?). Lancet i, 1378, 1983.
8. Anderson MJ, Lewis E, Kidd IM, et al: An outbreaak of erythema infectiosum associated with human parvovirus infection. J Hyg 93, 85, 1984.
9. Plummer FA, Hammond GW, Forward K, et al: An Erythema infectiosum-like illness caused by human parvovirus infection. NEJM 313, 74, 1985.
10. White DG, Mortimer PP, Blake DR, et al: Human parvovirus arthropathy. Lancet i, 419, 1985.
11. Reid DM, Brown T, Reid TM, et al: Human Parvovirus-associated arthritis: a clinical and laboratory description. Lancet i, 422, 1985.
12. Chorba T, Coccia P, Holman RC, et al: The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 154, 383, 1986.
13. Anderson MJ, Higgins PG, Davis IR: Experimental parvoviral infection in humans. J Infect Dis 152, 257, 1985.
14. Brown T, Anand A, Richtie LD, et al: Intrauterine parvovirus infection associated withidrops fetais. Lancet ii, 1033, 1984.
15. Mortimer PP, Cohen BJ, Buckley MM: Human parvovirus and the fetus. Lancet ii, 1612, 1985.
16. Bond PR, Caul EO, Usher J, et al: Intrauterine infection with human parvovirus. Lancet i, 448, 1986.
17. Kimney JS, Anderson LJ, Farrar J, et al: Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 157, 663, 1988.
18. American Academy of Pediatrics. Committee on infectious Diseases: Parvovirus, Erythema infectiosum, and Pregnancy. Pediatrics 85, 131, 1990.
19. Brown KL: Resistence to Parvovirus B19 infection due to the lack of virus receptor (Erythrocite P antigen). NEJM 330, 1192, 1994.
20. Smith MA, Shah NR, Lobel JS, et al: Severe anemia caused by human Parvovirus in a leukemia patient on maintenance chemotherapy. Clinical pediatrics 27, 383, 1998.
21. Frockhofen N: Persistent B19 Parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1). A treatable cause of anemia in AIDS. Ann Intern Med 113, 926, 1990.
22. Anderson LJ: Human Parvoviruses. J Infect Dis 161, 603, 1990.
23. Bell LM, Naides SJ, Stoffman P: Human parvovirus B19 infection among hospital staff members after contact with infected patients. NEJM 321, 485, 1989.
2. Mann JR, Carter KP, Walker RA, et al: Anaemic crisis in sickle cell disease. J Clin Path 28, 341, 1975.
3. Serjeant GR, Mason K, Topley JM, Serjeant NE: Outbreak of aplastic crises in sickle cell anaemia associated with parvoviru-like agent. Lancet ii, 595, 1981.
4. Rao KRP, Patel AR, Anderson MJ, et al: Infections with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med 98, 930, 1983.
5. Cohen BJ, Mortimer PP, Ferreira MS: Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus. J Hyg 91, 113, 1983.
6. Couronce AM, Ferchal F, Morinet F, et al: Human parvovirus infections in France. Lancet i, 160, 1984
7. Anderson MJ, Jones SE, Fisher-Hoch SP, et al: Human parvovirus. The cause of erithema infectiosum (fifth disease?). Lancet i, 1378, 1983.
8. Anderson MJ, Lewis E, Kidd IM, et al: An outbreaak of erythema infectiosum associated with human parvovirus infection. J Hyg 93, 85, 1984.
9. Plummer FA, Hammond GW, Forward K, et al: An Erythema infectiosum-like illness caused by human parvovirus infection. NEJM 313, 74, 1985.
10. White DG, Mortimer PP, Blake DR, et al: Human parvovirus arthropathy. Lancet i, 419, 1985.
11. Reid DM, Brown T, Reid TM, et al: Human Parvovirus-associated arthritis: a clinical and laboratory description. Lancet i, 422, 1985.
12. Chorba T, Coccia P, Holman RC, et al: The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 154, 383, 1986.
13. Anderson MJ, Higgins PG, Davis IR: Experimental parvoviral infection in humans. J Infect Dis 152, 257, 1985.
14. Brown T, Anand A, Richtie LD, et al: Intrauterine parvovirus infection associated withidrops fetais. Lancet ii, 1033, 1984.
15. Mortimer PP, Cohen BJ, Buckley MM: Human parvovirus and the fetus. Lancet ii, 1612, 1985.
16. Bond PR, Caul EO, Usher J, et al: Intrauterine infection with human parvovirus. Lancet i, 448, 1986.
17. Kimney JS, Anderson LJ, Farrar J, et al: Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 157, 663, 1988.
18. American Academy of Pediatrics. Committee on infectious Diseases: Parvovirus, Erythema infectiosum, and Pregnancy. Pediatrics 85, 131, 1990.
19. Brown KL: Resistence to Parvovirus B19 infection due to the lack of virus receptor (Erythrocite P antigen). NEJM 330, 1192, 1994.
20. Smith MA, Shah NR, Lobel JS, et al: Severe anemia caused by human Parvovirus in a leukemia patient on maintenance chemotherapy. Clinical pediatrics 27, 383, 1998.
21. Frockhofen N: Persistent B19 Parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1). A treatable cause of anemia in AIDS. Ann Intern Med 113, 926, 1990.
22. Anderson LJ: Human Parvoviruses. J Infect Dis 161, 603, 1990.
23. Bell LM, Naides SJ, Stoffman P: Human parvovirus B19 infection among hospital staff members after contact with infected patients. NEJM 321, 485, 1989.